When will the TO bid come according to this analysis?
Why has it not happened already?
Would any other competitors such as Bayer, Amgen, Merck and Teva, a past TO bid suitor for SRX, want it?
Ann: CEO's Address to AGM, page-78
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $119.3K | 681.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2347668 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2180364 | 40 |
View Market Depth
| Last trade - 13.06pm 26/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |